▲ 2.42%
prev close
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
+1
1 buys · 0 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2023-12-05 | BNTXBioNTech SE - American Depositary Shares | Buy | $1,001 - $15,000 | 1017d ago | — |
2023-12-05
Josh Gottheimer
BNTX
Amount
$1,001 - $15,000
Filed
1017d ago
Recent News
Powered by Polygon.io
Pfizer's Non-Oncology Performance in Q3: Driving Factors to Watch
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy?
Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline
Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell?
Trade Timeline
Congressional activity, newest first
Josh Gottheimer
2023-12-05 · Purchase
$1,001 - $15,000